NEKTAR THERAPEUTICS (a Delaware corporation) 9,500,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 11th, 2004 • Nektar Therapeutics • Pharmaceutical preparations • New York
Nektar Therapeutics, a Delaware corporation (the “Company”), confirms its agreement with Lehman Brothers Inc. (the “Underwriter”), with respect to the issue and sale by the Company and the purchase by the Underwriter of the number of shares of Common Stock, par value $0.0001 per share, of the Company (“Common Stock”) set forth in Schedule A hereto, and with respect to the grant by the Company to the Underwriter of the option described in Section 2(b) hereof to purchase all or any part of 1,425,000 additional shares of Common Stock to cover over-allotments, if any. The aforesaid 9,500,000 shares of Common Stock (the “Initial Securities”) to be purchased by the Underwriter and all or any part of the 1,425,000 shares of Common Stock subject to the option described in Section 2(b) hereof (the “Option Securities”) are hereinafter called, collectively, the “Securities.”
